BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19748745)

  • 1. Environmental conditions, political economy, and rates of injection drug use in large US metropolitan areas 1992-2002.
    Roberts ET; Friedman SR; Brady JE; Pouget ER; Tempalski B; Galea S
    Drug Alcohol Depend; 2010 Jan; 106(2-3):142-53. PubMed ID: 19748745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.
    Brady JE; Friedman SR; Cooper HL; Flom PL; Tempalski B; Gostnell K
    J Urban Health; 2008 May; 85(3):323-51. PubMed ID: 18344002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimates of the population prevalence of injection drug users among hispanic residents of large US metropolitan areas.
    Pouget ER; Friedman SR; Cleland CM; Tempalski B; Cooper HL
    J Urban Health; 2012 Jun; 89(3):527-64. PubMed ID: 22411420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.
    Tempalski B; Lieb S; Cleland CM; Cooper H; Brady JE; Friedman SR
    J Urban Health; 2009 Jan; 86(1):132-54. PubMed ID: 19015995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the prevalence of injection drug use among black and white adults in large U.S. metropolitan areas over time (1992--2002): estimation methods and prevalence trends.
    Cooper HL; Brady JE; Friedman SR; Tempalski B; Gostnell K; Flom PL
    J Urban Health; 2008 Nov; 85(6):826-56. PubMed ID: 18709555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends over time in HIV prevalence among people who inject drugs in 89 large US metropolitan statistical areas, 1992-2013.
    Williams LD; Ibragimov U; Tempalski B; Stall R; Satcher Johnson A; Wang G; Cooper HLF; Friedman SR
    Ann Epidemiol; 2020 May; 45():12-23. PubMed ID: 32439148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contextual Predictors of Injection Drug Use Among Black Adolescents and Adults in US Metropolitan Areas, 1993-2007.
    Cooper HL; West B; Linton S; Hunter-Jones J; Zlotorzynska M; Stall R; Wolfe ME; Williams L; Hall HI; Cleland C; Tempalski B; Friedman SR
    Am J Public Health; 2016 Mar; 106(3):517-26. PubMed ID: 26691126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the prevalence of injection drug use among adolescents and young adults in large U.S. metropolitan areas.
    Chatterjee S; Tempalski B; Pouget ER; Cooper HL; Cleland CM; Friedman SR
    AIDS Behav; 2011 Oct; 15(7):1570-8. PubMed ID: 21739288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma Surveillance - United States, 2006-2018.
    Pate CA; Zahran HS; Qin X; Johnson C; Hummelman E; Malilay J
    MMWR Surveill Summ; 2021 Sep; 70(5):1-32. PubMed ID: 34529643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation Analysis.
    McLinden T; Moodie EEM; Hamelin AM; Harper S; Walmsley SL; Paradis G; Aibibula W; Klein MB; Cox J
    AIDS Behav; 2017 Dec; 21(12):3496-3505. PubMed ID: 28726043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993-2007.
    Tempalski B; Cleland CM; Williams LD; Cooper HLF; Friedman SR
    Subst Abuse Treat Prev Policy; 2018 Aug; 13(1):28. PubMed ID: 30092806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.
    Tempalski B; Cooper HL; Friedman SR; Des Jarlais DC; Brady J; Gostnell K
    Int J Drug Policy; 2008 Apr; 19 Suppl 1(Suppl 1):S47-58. PubMed ID: 18295468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users.
    Friedman SR; Tempalski B; Cooper H; Perlis T; Keem M; Friedman R; Flom PL
    J Urban Health; 2004 Sep; 81(3):377-400. PubMed ID: 15273263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV among injection drug users in large US metropolitan areas, 1998.
    Friedman SR; Lieb S; Tempalski B; Cooper H; Keem M; Friedman R; Flom PL
    J Urban Health; 2005 Sep; 82(3):434-45. PubMed ID: 16014877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor-Active Surveillance in Selected Sites, United States, 2014-2017.
    Zhang AY; Shrum S; Williams S; Petnic S; Nadle J; Johnston H; Barter D; Vonbank B; Bonner L; Hollick R; Marceaux K; Harrison L; Schaffner W; Tesini BL; Farley MM; Pierce RA; Phipps E; Mody RK; Chiller TM; Jackson BR; Vallabhaneni S
    Clin Infect Dis; 2020 Oct; 71(7):1732-1737. PubMed ID: 31676903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America.
    Friedman SR; Tempalski B; Brady JE; Friedman JJ; Cooper HL; Flom PL; McGrath MM; Gostnell K; Des Jarlais DC
    Int J Drug Policy; 2007 Dec; 18(6):475-85. PubMed ID: 18061873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/AIDS among men who have sex with men and inject drugs--United States, 1985-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Jun; 49(21):465-70. PubMed ID: 10882293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage.
    Platt L; Hickman M; Rhodes T; Mikhailova L; Karavashkin V; Vlasov A; Tilling K; Hope V; Khutorksoy M; Renton A
    Addiction; 2004 Nov; 99(11):1430-8. PubMed ID: 15500596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injection drug use, food insecurity, and HIV-HCV co-infection: a longitudinal cohort analysis.
    McLinden T; Moodie EEM; Harper S; Hamelin AM; Anema A; Aibibula W; Klein MB; Cox J
    AIDS Care; 2018 Oct; 30(10):1322-1328. PubMed ID: 29716392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.